KY
Kyntra Bio, Inc. (KYNB)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$3.86
+3.49%
Mkt Cap $29.69M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$28.00
Range $28.00 – $28.00
Implied Upside
+625.4%
Consensus $28.00 vs current $3.86